MedTrace Logo

Non-contrast Abbreviated MRI for Secondary Surveillance of HCC

NCT05690451 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2024-06-25

No results posted yet for this study

Summary

This prospective multicenter study aimed to compare the diagnostic performance of non-contrast abbreviated MRI in detecting recurrent HCC after curative treatment to that of contrast-enhanced liver CT.

Conditions

Interventions

DIAGNOSTIC_TEST

non-contrast abbreviated MRI

Liver MRI without contrast injection. The following sequences will be obtained from all of the participants. * Axial heavily and regular T2 WI * precontrast fat-suppressed T1 WI * Diffusion-weighted image using b-value of 0, 50 or 400, and 800 or 1000

DIAGNOSTIC_TEST

Contrast enhanced liver CT

Liver CT with iodine contrast injection This test will be served as a standard diagnostic test. The following phases will be obtained * precontast, arterial phase, portal venous phase and delayed phase

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Dong Ho Lee, M.D. · Seoul National University Hospital

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-28
Primary Completion
2024-06-22
Completion
2024-06-22

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05690451 on ClinicalTrials.gov